B Group Inc’s Soleno Therapeutics SLNO Stock Holding History

B Group Inc’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,500	Closed	-$251K	–	22
2026 Q1	$251K	Buy	+7,500	New	+$294K	0.19%	19

B Group Inc's SLNO Position: Q2 2026 in Review

B Group Inc sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 7,500 shares — an estimated $251K sold.

B Group Inc first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $251K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

B Group Inc reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
B Group Inc sold 7,500 Soleno Therapeutics shares in Q2 2026, an estimated $251K.
B Group Inc first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
B Group Inc's Soleno Therapeutics position peaked at $251K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.